| |
HCV
|
Aβ42
|
Aβ40
|
p-Tau
|
t-Tau
|
MMSE
|
CDR-sb
|
CERAD-DR
|
Aβ42/Aβ40
|
|---|
|
HCV
| |
ns
|
0.03
|
ns
|
ns
|
ns
|
ns
|
ns
|
ns
|
|
Aβ42
| | |
ns
|
ns
|
ns
|
ns
|
ns
|
ns
|
ns
|
|
Aβ40
| | | |
0.02
|
0.00
|
0.04
|
0.02
|
0.05
|
0.06
|
|
p-Tau
| | | | |
0.03
|
ns
|
ns
|
ns
|
ns
|
|
t-Tau
| | | | | |
ns
|
ns
|
ns
|
0.02
|
|
MMSE
| | | | | | |
ns
|
ns
|
ns
|
|
CDR-sb
| | | | | | | |
ns
|
ns
|
|
CERAD-DR
| | | | | | | | |
ns
|
- Significant values are shown in bold typeface
- Data were not corrected for multiple testing
- For comparing areas under the curve we used a bootstrapping algorithm as implemented in pROC packages (Version 1.8)
-
Aβ40 amyloid-beta1–40, Aβ42 amyloid-beta1–42, CDR-sb Clinical Dementia Rating–sum-of-boxes, CERAD-DR Consortium to Establish a Registry of Dementia–delayed recall, HCV hippocampal volume, MMSE Mini-Mental State Examination, ns not significant, p-Tau phosphorylated tau, t-Tau total tau
